Stelis Biopharma Pvt Ltd - Product Pipeline Review

Global Markets Direct’s, ‘Stelis Biopharma Pvt Ltd - Product Pipeline Review - 2016’, provides an overview of the Stelis Biopharma Pvt Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Stelis Biopharma Pvt Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Stelis Biopharma Pvt Ltd

The report provides overview of Stelis Biopharma Pvt Ltd including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Stelis Biopharma Pvt Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Stelis Biopharma Pvt Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Stelis Biopharma Pvt Ltd’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Stelis Biopharma Pvt Ltd

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Stelis Biopharma Pvt Ltd’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Introduction 4

Global Markets Direct Report Coverage 4

Stelis Biopharma ...

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Introduction 4

Global Markets Direct Report Coverage 4

Stelis Biopharma Pvt Ltd Snapshot 5

Stelis Biopharma Pvt Ltd Overview 5

Key Facts 5

Stelis Biopharma Pvt Ltd - Research and Development Overview 6

Key Therapeutic Areas 6

Stelis Biopharma Pvt Ltd - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Stelis Biopharma Pvt Ltd - Pipeline Products Glance 12

Stelis Biopharma Pvt Ltd - Clinical Stage Pipeline Products 12

Phase I Products/Combination Treatment Modalities 12

Stelis Biopharma Pvt Ltd - Early Stage Pipeline Products 13

Preclinical Products/Combination Treatment Modalities 13

Stelis Biopharma Pvt Ltd - Drug Profiles 14

SBL-005 - Drug Profile 14

Product Description 14

Mechanism Of Action 14

R&D Progress 14

SBL-011 - Drug Profile 15

Product Description 15

Mechanism Of Action 15

R&D Progress 15

SBL-012 - Drug Profile 16

Product Description 16

Mechanism Of Action 16

R&D Progress 16

teriparatide biosimilar - Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

Stelis Biopharma Pvt Ltd - Pipeline Analysis 18

Stelis Biopharma Pvt Ltd - Pipeline Products by Target 18

Stelis Biopharma Pvt Ltd - Pipeline Products by Route of Administration 19

Stelis Biopharma Pvt Ltd - Pipeline Products by Molecule Type 20

Stelis Biopharma Pvt Ltd - Pipeline Products by Mechanism of Action 21

Stelis Biopharma Pvt Ltd - Dormant Projects 22

Stelis Biopharma Pvt Ltd - Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Appendix 24

Methodology 24

Coverage 24

Secondary Research 24

Primary Research 24

Expert Panel Validation 24

Contact Us 24

Disclaimer 25

List of Tables

List of Tables

Stelis Biopharma Pvt Ltd, Key Facts 5

Stelis Biopharma Pvt Ltd - Pipeline by Indication, 2016 7

Stelis Biopharma Pvt Ltd - Pipeline by ...

List of Tables

Stelis Biopharma Pvt Ltd, Key Facts 5

Stelis Biopharma Pvt Ltd - Pipeline by Indication, 2016 7

Stelis Biopharma Pvt Ltd - Pipeline by Stage of Development, 2016 8

Stelis Biopharma Pvt Ltd - Monotherapy Products in Pipeline, 2016 9

Stelis Biopharma Pvt Ltd - Partnered Products in Pipeline, 2016 10

Stelis Biopharma Pvt Ltd - Partnered Products/ Combination Treatment Modalities, 2016 11

Stelis Biopharma Pvt Ltd - Phase I, 2016 12

Stelis Biopharma Pvt Ltd - Preclinical, 2016 13

Stelis Biopharma Pvt Ltd - Pipeline by Target, 2016 18

Stelis Biopharma Pvt Ltd - Pipeline by Route of Administration, 2016 19

Stelis Biopharma Pvt Ltd - Pipeline by Molecule Type, 2016 20

Stelis Biopharma Pvt Ltd - Pipeline Products by Mechanism of Action, 2016 21

Stelis Biopharma Pvt Ltd - Dormant Developmental Projects,2016 22

Stelis Biopharma Pvt Ltd, Subsidiaries 23

List of Figures

List of Figures

Stelis Biopharma Pvt Ltd - Pipeline by Indication, 2016 7

Stelis Biopharma Pvt Ltd - Pipeline by Stage of Development, 2016 8

Stelis Biopharma ...

List of Figures

Stelis Biopharma Pvt Ltd - Pipeline by Indication, 2016 7

Stelis Biopharma Pvt Ltd - Pipeline by Stage of Development, 2016 8

Stelis Biopharma Pvt Ltd - Monotherapy Products in Pipeline, 2016 9

Stelis Biopharma Pvt Ltd - Pipeline by Molecule Type, 2016 20

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports